Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.
Which exact product, version and licensed modules are in the current offer?
Do related FDA submissions document the same scope, or different functions and versions?
Which costs, support obligations and local acceptance tests remain unresolved?
Authorized purpose: Rapid Neuro3D analyzes adult head-and-neck CTA DICOM from the aortic arch to the vertex, removing bone, tissue, and venous vessels to generate 3D/2D neurovascular visualizations, including MIP, volume-rendered, and CPR views of carotid and vertebral arteries for trained physicians' lesion review and planning; results are not standalone clinical decisions.
Authorized purpose: Adjunct assessment of early ischemic brain tissue injury and extent of disease in adult ischemic-stroke diagnostic imaging workup, typically within 24 hours of last known well
Authorized purpose: Rapid Platform v6.0 is image-processing software for trained professionals that views, processes, and analyzes DICOM images from CT and MRI. It supports functional and dynamic datasets including CT perfusion, CT angiography, diffusion-weighted MRI, and dynamic contrast-enhanced CT or MRI, with maps and measurements for tissue perfusion, diffusion, and blood volume. Rapid CT-Perfusion and Rapid MR-Perfusion may aid physicians in selecting acute stroke patients with known occlusion of the intracranial internal carotid artery or proximal middle cerebral artery for endovascular thrombectomy, subject to the labeled imaging criteria, clinical requirements, and exclusions.
Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain and intracranial vessels represented in CT perfusion, CTA, and MRI; tissue perfusion, diffusion, and contrast dynamics
Authorized purpose: Triage and notification of suspected hemispheric subdural hemorrhage (SDH) on non-enhanced head CT, in parallel with standard-of-care interpretation; not diagnostic.
Authorized purpose: Assist hospital networks and trained radiologists in routine-care workflow triage by flagging and prioritizing adult studies with suspected unruptured saccular brain aneurysms at least 4 mm in diameter; compressed previews are informational and not for diagnostic use.
Authorized purpose: Triage and notification for suspected intracranial hemorrhage and non-contrast CT large-vessel occlusion involving the ICA and MCA-M1.
Modality
CT/CTA
Anatomy
Brain/head, including ICH and ICA/MCA-M1 LVO findings.
Authorized purpose: Assist hospital networks and trained radiologists with workflow triage by flagging and communicating suspected IPH, IVH, SAH, and SDH findings in non-enhanced head CT images.
Modality
CT/CTA
Anatomy
Head/brain; suspected intraparenchymal, intraventricular, subarachnoid, and subdural intracranial hemorrhage.
Authorized purpose: Assist hospital networks and trained radiologists with workflow triage by flagging and communicating suspected ICA or MCA-M1 large-vessel occlusion findings in head CTA images.
Modality
CT/CTA
Anatomy
Head/brain vasculature, specifically the intracranial ICA and MCA-M1 segments.
Authorized purpose: Adjunct evaluation of extent of early ischemic brain injury in patients with known MCA or ICA occlusion during stroke imaging interpretation within 6 hours
Authorized purpose: iSchemaView RAPID processes CT perfusion, CTA, and MR studies to visualize and analyze diffusion and perfusion, including tissue blood-volume maps, and supports physician selection of eligible acute-stroke patients with known intracranial ICA or proximal MCA occlusion for thrombectomy.
Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain, intracranial vasculature, and perfusion regions